Report cover image

U.S. Digital Therapeutics Market, By Application ((Treatment & Disease Management (Chronic Care, Mental Health & Neurological Disorders, and Others) and Preventive Care (Pre-diabetes, Weight Management, and Others)) and By End User (Healthcare Providers,

Publisher Coherent Market Insights
Published Mar 26, 2025
Length 157 Pages
SKU # CMI20008367

Description

Digital therapeutics (DTx) are evidence-based therapeutic interventions, driven by the high quality software programs, to prevent, manage, or treat a medical disorder or disease. DTx have potential to reduce disease burdens, deliver better clinical outcomes, and improve patients’ lives by offering better ways to manage chronic health conditions.

Market Dynamics:

Rise in burden of chronic diseases, outbreak of COVID-19 (pandemic), growing adoption of digital healthcare, rise in adoption of novel technologies, and favorable government initiatives (support) are major factors expected to augment growth of the US digital therapeutics market.

For instance, in September 2022, the U.S. Food & Drug Administration (USFDA) announced the launch of the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH). The launch of the Digital Health Center of Excellence is a vital step in furthering the agency’s overarching dedication to the advancement of digital health technology, including mobile health devices, Software as a Medical Device (SaMD), wearables when used as a medical device, and technologies used to study medical products.

Key features of the study:
  • This report provides in-depth analysis of the US digital therapeutics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the US digital therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include 2Morrow Inc., ResMed, Pear Therapeutics, Omada Health Inc., Teladoc Health, Lark Technologies, Kaia Health, Fitbit, Cognoa Inc., and Akili Interactive Labs, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The US digital therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the US digital therapeutics market.
Detailed Segmentation:
  • U.S. Digital Therapeutics Market, By Application:
  • Treatment & Disease Management
  • Chronic Care
  • Mental Health & Neurological Disorders
  • Others
  • Preventive Care
  • Pre-diabetes
  • Weight Management
  • Others
  • U.S. Digital Therapeutics Market, By End User:
  • Healthcare Providers
  • Patients/Individuals
  • Payers
  • Employers
  • Others
  • Company Profiles:
  • 2Morrow Inc.
  • ResMed
  • Pear Therapeutics
  • Omada Health Inc.
  • Teladoc Health
  • Lark Technologies
  • Kaia Health
  • Fitbit
  • Cognoa Inc.
  • Akili Interactive Labs

Table of Contents

157 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Application
Market Snapshot, By End User
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Growing adoption of digital healthcare/technologies
Growing concerns about patient data privacy
The outbreak of COVID-19 (pandemic)
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. U.S. Digital Therapeutics Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. U.S. Digital Therapeutics Market, By Application, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Treatment & Disease Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 -2032,(US$ Bn)
Chronic Care
Mental Health & Neurological Disorders
Others
Preventive Care
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pre-diabetes
Weight Management
Others
6. U.S. Digital Therapeutics Market, By End User, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Healthcare Providers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Patients/Individuals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Payers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Employers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Competitive Landscape
2Morrow Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
ResMed
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pear Therapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Omada Health Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teladoc Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Lark Technologies
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Kaia Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Fitbit
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Cognoa Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Akili Interactive Labs
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
8. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on U.S. Digital Therapeutics Market” - forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us